Clinical Trial

Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

Study acronym: Delta-AI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Cancer can develop in the colon, or large bowel. Examination of the colon with a tube fitted with a camera is called a colonoscopy. Colonoscopy allows detection of small growths in the colon, called "polyps". Polyps can often be removed during colonoscopy. Some of these polyps are called adenomas and can become cancer after several years. A good colonoscopy aims to find and take out as many of these polyps as possible. A quality indication of colonoscopy is the "adenoma detection rate" (ADR). It should be high, meaning many polyps are detected and taken out. New artificial intelligence devices to assist colonoscopy seem to increase the ADR, and maybe help prevent cancer even better than normal colonoscopy. The goal of this clinical trial is to compare the ADR when using standard colonoscopy to the ADR with artificial intelligence (AI)-assisted colonoscopy.
Trial Details
NCT Number NCT06792292
Lead Sponsor Chirec
Conditions Artificial Intelligence, Colonic Adenoma, Colonic Neoplasms, Colonic Polyp, Colonoscopy
Enrollment 765 participants
Start Date 2025-02-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-24